medline.ch Onkologie Urologische Tumoren

	Multilayered analysis of cisplatin resistance mechanisms in bladder cancer: from the cell membrane to organelles. PeerJ Ma L, Tao Y, Cheng L, You C, Xiao X, Yang W, Liu Y, Dong Z. PMID: 42052167 [PubMed - indexed for MEDLINE]
	Detection rate of [(99m)Tc]Tc-PSMA SPECT/CT in prostate cancer: a systematic review and a meta-analysis. Front Med (Lausanne) Albano D, Tasevski S, Sadeghi R, Treglia G, Rizzo A. PMID: 42051703 [PubMed]
	A multidimensional nomogram integrating immune, inflammatory, and coagulation markers for personalized prognosis in bladder cancer. J Int Med Res Li Y, Wei W, Liu C, Lu H, Chen R, Wu S, Lin Y, Xie H, Ban C, Yi X, Tang Y. PMID: 42050916 [PubMed - indexed for MEDLINE]
	Indirect Comparison of Neoadjuvant Treatment Strategies for Muscle-Invasive Bladder Cancer: ddMVAC and Perioperative Durvalumab-Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. Int J Cancer Mangold MH, Baumann G, Wieland VLS, Carl N, Renner LV, Studier-Fischer A, Menold H, Zschäbitz S, Wessels F, Westhoff N, Michel MS, Kowalewski KF, Haney-Aubert CM. PMID: 42050770 [PubMed - as supplied by publisher]
	Neoadjuvant hormone therapy plus robot-assisted radical prostatectomy improves pathologic outcomes in high-risk prostate cancer: a retrospective cohort study. BMC Urol Fan J, Liu S, Li Z, Xv Y, Li T, Huang S, Feng C, Liu J, Li D, Jiang F. PMID: 42050599 [PubMed - as supplied by publisher]
	Long-term risk of depression in lung, colon, breast, and prostate cancer: a 25-year nationwide comparative study. BMC Cancer Borg M, Farver-Vestergaard I, Hilberg O, Steed L, Nissen L, Ibsen R, Løkke A. PMID: 42050470 [PubMed - as supplied by publisher]
	Correction: Clinically significant prostate cancer detection with deep learning in a multi-center magnetic resonance imaging study. Sci Rep Alzate-Grisales JA, Mora-Rubio A, Perán-Teruel M, Beltrán AN, Torres CR, García JMO, García-García F, Tabares-Soto R, García-Gómez JM, de la Iglesia-Vayá M. PMID: 42050081 [PubMed - in process]
	Evaluating Clinically Significant Prostate Cancer with Pathology-Registered Radiomics: A Multi-Reader Assessment Using Lesion Diameter-based Simplified Segmentations on MRI. Acad Radiol Esengur OT, Harmon SA, Gelikman DG, Yilmaz EC, Zhang H, Simon B, An JY, Azamat S, Law YM, Margolis DJA, Marko J, Panebianco V, Merino MJ, Gurram S, Wood BJ, Lis R, Choyke PL, Pinto PA, Turkbey B. PMID: 42049617 [PubMed - as supplied by publisher]
	European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 Guidelines. Eur Urol Patrikidou A, Cazzaniga W, Oing C, Berney D, Lobo J, Boormans J, Fankhauser C, Fischer S, Leao R, Gravina C, Nardo DD, Cornes R, Janisch F, Bezuidenhout C, Haugnes HS, Papachristofilou A, Tandstad T, Heidenreich A. PMID: 42049597 [PubMed - as supplied by publisher]
	Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol Sherry AD, To V, D'souza C, Kiany S, Thio N, Liu S, Sun X, Castle B, Macdonald S, Choi H, Seo A, Hara K, Pryor D, Azad A, Tran B, Au L, Spain L, Ludmir EB, Jonasch E, Tannir NM, Msaouel P, Neeson P, Haymaker C, Tang C, Siva S. PMID: 42049596 [PubMed - as supplied by publisher]
	European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update. Eur Urol Parnham A, Albersen M, Ayres B, Crook J, Johnstone PAS, Oliveira P, Pagliaro LC, Pettaway C, Protzel C, Bryan Rumble R, Sánchez Martínez DF, Spiess PE, van der Heijden MS, Barreto L, Garcia-Perdomo HA, Greco I, Patterson K, Manzie K, Marcus JD, Osborne J, Bezuidenhout C, Tagawa S, Brouwer O. PMID: 42049595 [PubMed - as supplied by publisher]
	Reply to Ashwini Kadam, Ankit Misra and Gagan Prakash's Letter to the Editor Re: Chase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al. Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic Pathway. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.10.015. Eur Urol Ng CPY, Light A, Ahmed H, Shah T. PMID: 42049594 [PubMed - as supplied by publisher]
	Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine Cytology. Clin Genitourin Cancer Kravchuk A, Garzaro JRR, Wirtz R, Wolff I, Koch S, Schlomm T, Rabien A, Meisl C, Rong D, Brás JP, Vinagre J, Otto T, Barski D, Gössl A, Siepmann S, Gilfrich C, Brookman-May S, Ecke T, May M. PMID: 42049549 [PubMed - as supplied by publisher]
	Older Age and Outcomes of Intravesical Bacillus Calmette-GuÃ©rin for Non-muscle-invasive Bladder Cancer. In Vivo Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T. PMID: 42049417 [PubMed - indexed for MEDLINE]
	Risk Factors and Clinical Significance of Grade â‰¥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer. In Vivo Sato R, Yoshimi Y, Nishio T, Matsunaga YU, Matsumoto R. PMID: 42049400 [PubMed - indexed for MEDLINE]
	Does Irradiation of Pelvic Lymph Nodes Have an Impact on the Bladder Filling Status in Patients With High-risk Prostate Cancer? In Vivo Rades D, Doehring L, Küter JD, Kristiansen C, Vestergård-Madsen C, Schulz CF, Janssen S. PMID: 42049398 [PubMed - indexed for MEDLINE]
	Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP Grade. Anticancer Res Hamada K, Yamasaki T, Ohe C, Tsujio N, Yamamoto S, Matsue T, Yukimatsu N, Otoshi T, Kato M, Kuratsukuri K, Shiohara M, Kohashi K, Uchida J. PMID: 42049363 [PubMed - indexed for MEDLINE]
	Early Progressive Disease Predicts Poor Outcomes of Second-line VEGFR Tyrosine Kinase Inhibitor Therapy After First-line Nivolumab Plus Ipilimumab in Advanced Renal Cell Carcinoma. Anticancer Res Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T. PMID: 42049357 [PubMed - indexed for MEDLINE]
	Real-world Delivery and Outcomes of Intravesical BCG for Non-muscle-invasive Bladder Cancer. Anticancer Res Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T. PMID: 42049353 [PubMed - indexed for MEDLINE]
	A Reminder App for Optimizing Bladder Filling During Radiotherapy for Prostate Cancer: A Pre-study in Healthy Volunteers. Anticancer Res Rades D, Narvaez-Wolf CA, Zwaan IC, Vestergård-Madsen C, Kristiansen C, Küter JD. PMID: 42049338 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 177834

Seite 1 von 8892

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung